Showing results (201-210 of 286) with videos related to

Sort By:
Pageof 29
Critical Care Medicine|December 10, 2015
Incidence and Outcomes of Cardiopulmonary Resuscitation in PICUsRobert A Berg, Vinay M Nadkarni, Amy E Clark, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|January 22, 2019
Development of the Pediatric Extracorporeal Membrane Oxygenation Prediction Model for Risk-Adjusting MortalityDavid K Bailly, Ron W Reeder, Melissa Winder, et al.
Perfusion|February 28, 2022
Anticoagulation practices associated with bleeding and thrombosis in pediatric extracorporeal membrane oxygenation; a multi-center secondary analysisDavid K Bailly, Ron W Reeder, Jennifer A Muszynski, et al.
Hospital Pediatrics|August 21, 2024
Unit-based Pathways to Reduce InequitieS for familiEs speaking languages other than English (UPRISE)Jennie N Magana-Soto, Monica O Ruiz, Daniel S Tawfik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group studyTerzah M Horton, Debananda Pati, Sharon E Plon, et al.
Neuro-Oncology|August 22, 2008
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I studyKristin A Bradley, Ian F Pollack, Joel M Reid, et al.
European Journal of Clinical Pharmacology|October 3, 2009
Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 monthsJohn T Mondick, Brendan M Johnson, Lynda J Haberer, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group studyErin Cooney-Qualter, Mark Krailo, Anne Angiolillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium reportBrigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.
Pageof 29